TF and cancer: Moreover, laboratory parameters (e.g., hemoglobin, platelets, and leukocytes) and other biomarkers (e.g., TF, TF-microparticles, thrombin, pro-inflammatory cytokines, soluble P-selectin, D-dimer and CRP) are predictive markers for the risk of VTE in cancer patients and have been used to enhance risk stratification [5, 6].